Fast Acting Topical Cream for Erectile Dysfunction
Fast Acting Topical Cream for Erectile Dysfunction
40% Of men are affected by ED at age 40
70% Of men are affected by ED by age 70
$4 BILLION CURRENT ED TREATMENT SALES EXCEED $4 BILLION AND ARE GROWING WITH AN AGING POPULATION
Market demand is estimated at more than 2x current levels. For many men, present treatments are not effective, or not allowed due to other health conditions, or are too expensive, painful, and uncomfortable to use.
Estimated $300 - $500B market sales US and EU
Caverject® is the FDA approved injected version of Madera’s active drug
$80 to $130 per dose in US.
Effective, approved drug using the active ingredient in Madera
Fast acting, effective and safe
Extremely unpleasant to use
US pricing is $80 per dose
$1.4B market sales
Devices and surgery can be expensive, socially awkward, often painful and desperate measures
External topicals and sprays
Use evaporation/ organic volatiles to elicit a response
Requires a healthy male for effect
$2B sales market
Target market limited to healthy men without heart conditions or nerve damage
Doesn’t work on 30-40% of men
Many systemic side effects
Copyright © 2024 Madera Pharmaceuticals - All Rights Reserved.
Powered by Godaddy